These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31629431)

  • 1. Considerations of germline testing in prostate cancer screening.
    Polascik TJ; Orabi H
    Can J Urol; 2019 Oct; 26(5 Suppl 2):46-47. PubMed ID: 31629431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice.
    Giri VN; Hyatt C; Leader A
    J Urol; 2020 Dec; 204(6):1116-1118. PubMed ID: 32926644
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline testing in those at risk of prostate cancer.
    Carroll PR; Witte JS; Parsons JK
    Can J Urol; 2019 Oct; 26(5 Suppl 2):31-33. PubMed ID: 31629425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic disparities among men with prostate cancer undergoing germline testing.
    Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
    Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically Informed Prostate Cancer Screening.
    Arcot R; Morgan TM; Polascik TJ
    Urol Clin North Am; 2021 Aug; 48(3):373-386. PubMed ID: 34210492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of prostate cancer and its utility in treatment and screening.
    Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
    Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic predisposition to prostate cancer: an update.
    Ni Raghallaigh H; Eeles R
    Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations of multigene test findings among men with prostate cancer - knowns and unknowns.
    AlDubayan SH
    Can J Urol; 2019 Oct; 26(5 Suppl 2):14-16. PubMed ID: 31629418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urology perspective on the expanding world of germline testing for prostate cancer.
    Cookson MS
    Can J Urol; 2019 Oct; 26(5 Suppl 2):5-6. PubMed ID: 31629413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reimagining prostate cancer screening: the IMPACT of germline mutations.
    Gandaglia G; Briganti A; Montorsi F
    Lancet Oncol; 2021 Nov; 22(11):1491-1492. PubMed ID: 34678157
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
    de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
    Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S; Giri VN
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
    J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.
    Harper JB; Greenberg SE; Hunt TC; Cooney KA; O'Neil BB
    Prostate; 2023 Feb; 83(2):151-157. PubMed ID: 36207779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in germline testing among racial minorities with prostate cancer.
    Weise N; Shaya J; Javier-Desloges J; Cheng HH; Madlensky L; McKay RR
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):403-410. PubMed ID: 34775478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
    Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
    Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to use germline genetic testing in prostate cancer.
    Giri VN
    Clin Adv Hematol Oncol; 2022 Feb; 20(2):78-81. PubMed ID: 35120087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.